Toxic bile and sclerosing cholangitis: Is there a role for pharmacological interruption of the bile acid enterohepatic circulation?
- PMID: 26600416
- PMCID: PMC4718786
- DOI: 10.1002/hep.28363
Toxic bile and sclerosing cholangitis: Is there a role for pharmacological interruption of the bile acid enterohepatic circulation?
Comment on
-
Pharmacological inhibition of apical sodium-dependent bile acid transporter changes bile composition and blocks progression of sclerosing cholangitis in multidrug resistance 2 knockout mice.Hepatology. 2016 Feb;63(2):512-23. doi: 10.1002/hep.27973. Epub 2015 Aug 21. Hepatology. 2016. PMID: 26172874 Free PMC article.
Similar articles
-
Pharmacological inhibition of apical sodium-dependent bile acid transporter changes bile composition and blocks progression of sclerosing cholangitis in multidrug resistance 2 knockout mice.Hepatology. 2016 Feb;63(2):512-23. doi: 10.1002/hep.27973. Epub 2015 Aug 21. Hepatology. 2016. PMID: 26172874 Free PMC article.
-
The case for combining treatments for primary sclerosing cholangitis.Lancet Gastroenterol Hepatol. 2018 Aug;3(8):526-528. doi: 10.1016/S2468-1253(18)30173-0. Lancet Gastroenterol Hepatol. 2018. PMID: 30047442 No abstract available.
-
Effect of SC-435 on the gastrointestinal migrating myoelectric complex in guinea pigs.Zhong Nan Da Xue Xue Bao Yi Xue Ban. 2005 Oct;30(5):497-503. Zhong Nan Da Xue Xue Bao Yi Xue Ban. 2005. PMID: 16320575
-
The role of the sodium-taurocholate cotransporting polypeptide (NTCP) and of the bile salt export pump (BSEP) in physiology and pathophysiology of bile formation.Handb Exp Pharmacol. 2011;(201):205-59. doi: 10.1007/978-3-642-14541-4_5. Handb Exp Pharmacol. 2011. PMID: 21103971 Review.
-
New therapies target the toxic consequences of cholestatic liver disease.Expert Rev Gastroenterol Hepatol. 2018 Mar;12(3):277-285. doi: 10.1080/17474124.2018.1424538. Epub 2018 Jan 10. Expert Rev Gastroenterol Hepatol. 2018. PMID: 29310470 Review.
Cited by
-
Sex-related factors in autoimmune liver diseases.Semin Immunopathol. 2019 Mar;41(2):165-175. doi: 10.1007/s00281-018-0715-8. Epub 2018 Oct 1. Semin Immunopathol. 2019. PMID: 30276446 Review.
-
Immune-mediated cholangiopathies in children: the need to better understand the pathophysiology for finding the future possible treatment targets.Front Immunol. 2023 Oct 20;14:1206025. doi: 10.3389/fimmu.2023.1206025. eCollection 2023. Front Immunol. 2023. PMID: 37928553 Free PMC article. Review.
-
Wnt-β-catenin in hepatobiliary homeostasis, injury, and repair.Hepatology. 2023 Dec 1;78(6):1907-1921. doi: 10.1097/HEP.0000000000000495. Epub 2023 May 30. Hepatology. 2023. PMID: 37246413 Free PMC article. Review.
References
-
- Kramer W, Glombik H. Bile acid reabsorption inhibitors (BARI): novel hypolipidemic drugs. Curr Med Chem. 2006;13:997–1016. - PubMed
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources